CN Patent

CN115768458A — CEBP-β拮抗剂的施用和使用方法

Assigned to Smart Therapy Ltd · Expires 2023-03-07 · 3y expired

What this patent protects

提供了施用CCAAT/增强子结合蛋白β(C/EBPβ)肽拮抗剂的方法和通过施用C/EBPβ肽拮抗剂来治疗实体瘤的方法。

USPTO Abstract

提供了施用CCAAT/增强子结合蛋白β(C/EBPβ)肽拮抗剂的方法和通过施用C/EBPβ肽拮抗剂来治疗实体瘤的方法。

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: CN115768458A
Jurisdiction: CN
Classification: —
Expires: 2023-03-07
Drug substance claim: No
Drug product claim: No
Assignee: Smart Therapy Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.